ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Post-Acute COVID-19 Syndrome
Infections
Human Influenza
Pneumonia
Virus Diseases
Respiratory Tract Infections

COVID-19 trials near Austin, TX, USA:

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults

The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID...

Active, not recruiting
COVID-19
Biological: CVXGA (CVXGA50)
Biological: COMIRNATY®

Phase 2

Cyanvac

Austin, Texas, United States and 54 other locations

of the study is to assess the safety and immunogenicity of IIV-HD (high-dose inactivated influenza vaccine) + rC19 (adjuvanted recombinant COVID...

Active, not recruiting
COVID-19 Immunization
Influenza Immunization
Biological: IIV-HD + rC19 (dose 4)
Biological: IIV-HD + rC19 (dose 3)

Phase 1, Phase 2

Sanofi
Sanofi

Austin, Texas, United States and 11 other locations

vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...

Active, not recruiting
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: VXA-CoV2-3.3

Phase 2

Vaxart

Austin, Texas, United States and 144 other locations

the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...

Enrolling
SARS-CoV-2
Biological: mRNA-1283
Biological: mRNA-1273

Phase 4

Moderna
Moderna

Austin, Texas, United States and 149 other locations

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health proble-...

Enrolling
COVID-19
SARS-COV-2 Infection
Biological: Placebo
Biological: BNT162b2 Vaccine

Phase 3

BioNTech
BioNTech

Austin, Texas, United States and 205 other locations

The purpose of this trial is to evaluate immunogenicity and safety of CVXGA administered as a single intranasal dose against SARS-CoV-2 S-protein in...

Active, not recruiting
COVID-19
Biological: CVXGA

Phase 2

Cyanvac

Cedar Park, Texas, United States and 9 other locations

This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...

Active, not recruiting
SARS-CoV-2 Infection
Biological: Intramuscular vaccine
Drug: Intramuscular injection

Phase 2, Phase 3

Medicago

Austin, Texas, United States of America and 90 other locations

The main goal of this study is to evaluate the safety, reactogenicity, and immunogenicity of study vaccines.

Active, not recruiting
Respiratory Syncytial Virus
Seasonal Influenza
Biological: FLUAD®
Biological: mRNA-1647

Phase 1

Moderna
Moderna

Austin, Texas, United States of America and 7 other locations

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab SC
Drug: Lecanemab IV

Phase 3

Eisai
Eisai

Austin, Texas, United States and 246 other locations

) neo-antigen in subjects with relapsing multiple sclerosis (RMS).COVID-19 sub-study:The purpose of this research sub-study is to e...

Active, not recruiting
Relapsing Multiple Sclerosis
Biological: 23-valent pneumococcal polysaccharide vaccine (23-PPV)
Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Phase 3

Novartis
Novartis

Round Rock, Texas, United States and 298 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems